Skip to main content

Prototype Prescribing Outlier Dashboard for Aylesham Medical Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Aylesham Medical Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Paraffin soft yellow 4 Tear deficiency, eye lubricant/astringent 7 0.57 0.01 0.02 34.43
Inclisiran 1 Lipid-regulating drugs 5,993 0.00 0.00 0.00 14.81
Oxazepam 43 Anxiolytics 204 0.21 0.01 0.02 8.65
Metformin hydrochloride/sitagliptin 370 Other antidiabetic drugs 1,769 0.21 0.01 0.03 7.61
Strontium ranelate 3 Bisphosphonates and other drugs 359 0.01 0.00 0.00 5.30
Eletriptan 18 Treatment of acute migraine 269 0.07 0.00 0.01 4.29
Low protein breads 9 Foods for special diets 194 0.05 0.00 0.01 3.98
Glipizide 10 Sulfonylureas 273 0.04 0.00 0.01 3.64
Pneumococcal 15 Vaccines and antisera 27 0.56 0.05 0.14 3.57
Doxepin hydrochloride 7 Topical local anaesthetics and antipruritics 35 0.20 0.01 0.05 3.51

Prescribing where Aylesham Medical Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Water for injection 1 Electrolytes and water 7 0.14 0.82 0.25 -2.75
Gliclazide 154 Sulfonylureas 273 0.56 0.93 0.13 -2.69
Chloramphenicol 31 Antibacterials 56 0.55 0.81 0.11 -2.36
Hypromellose 1 Tear deficiency, eye lubricant/astringent 7 0.14 0.45 0.15 -2.02
Influenza 9 Vaccines and antisera 27 0.33 0.88 0.28 -1.94
Tacrolimus 0 Corticosteroids and other immunosuppressants 13 0.00 0.63 0.40 -1.58
    Quinine sulfate 135 Antimalarials 198 0.68 0.90 0.14 -1.58
    Cetirizine hydrochloride 65 Antihistamines 569 0.11 0.28 0.11 -1.56
    Zinc oxide 0 Barrier preparations 1 0.00 0.49 0.33 -1.49
      Letrozole 32 Breast cancer 250 0.13 0.45 0.22 -1.48